March 2022

Sun Pharmaceutical Industries Limited is taking this opportunity balance employment and the medications for the world. We are hereby inviting candidates who are interested to join India's number one company in Pharmaceutical sector.

Officer / Sr. Officer (Quality Assurance - API) : Candidates having educational qualification of M.Sc. with experience of 4 to 8 years in Quality Assurance Department.

Bliss GVS is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. We are a public limited company listed on Indias National Stock Exchange and Bombay Stock Exchange with more than three decades of industry expertise. We are among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment.

Merck, a leading science and technology company, today announced in a European worksharing procedure (WSP) an extension to the label for metformin products in the EU - Glucophage (metformin hydrochloride [HCL] immediate release), Glucophage XR (metformin HCL extended release) and Stagid® (metformin embonate immediate release) - for use throughout pregnancy.

CTI BioPharma Corp announced the U.S. Food and Drug Administration (FDA) has approved VONJO (pacritinib) for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 × 10⁹/L. VONJO is a novel oral kinase inhibitor with specificity for JAK2 and IRAK1, without inhibiting JAK. The recommended dosage of VONJO is 200 mg orally twice daily.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel) for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.

Researchers find out in a recent study that omalizumab provides benefit to patients with moderate to severe allergic asthma, regardless of body mass index.

Bharat Biotech is in the process of bringing out a vaccine against tuberculosis and soon the firm will sign a MoU with another firm for technology.

"Our honourable Prime Minister has got an agenda of 2025 for the eradication of tuberculosis. I think we are in that direction. But we don't have the technology so we are partnering with somebody else. On that matter we should be announcing soon," Krishna Ella, Chairman and Managing Director said in BioAsia 2022.

Kolkata-based TABLT Pharmacy has raised USD 1.5 million in pre-series A round from investors like JITO Angel Network, Tech Innovation, Lets Venture, Seeders Syndicate, Angel Bay and other angel investors. Also, the founders have themselves participated in this round.

Tablt online pharmacy is launched in 2018 and it is dealing in medicines, OTCs and other healthcare products.